Results 171 to 180 of about 1,717,717 (307)

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Lethality rescue and long-term amelioration of a citrullinemia type I mouse model by neonatal gene-targeting combined to SaCRISPR-Cas9. [PDF]

Mol Ther Methods Clin Dev, 2023
Lisjak M, Iaconcig A, Guarnaccia C, Vicidomini A, Moretti L, Collaud F, Ronzitti G, Zentilin L, Muro AF.   +8 more
europepmc   +1 more source

Gene Targeting [PDF]

, 2020
openaire   +1 more source

gene targeting

Citation: 'gene targeting' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.10753 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms. Requests for commercial
openaire   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Homology-arm length of donor DNA affects the impact of Msh2 loss on homologous recombination-mediated gene targeting. [PDF]

Proc Natl Acad Sci U S A
Saito S, Suzuki T, Nohmi T, Adachi N.
europepmc   +1 more source

Gene targeting in polymerase theta-deficient Arabidopsis thaliana. [PDF]

Plant J, 2022
van Tol N, van Schendel R, Bos A, van Kregten M, de Pater S, Hooykaas PJJ, Tijsterman M.   +6 more
europepmc   +1 more source

Targeting p38α in cancer: challenges, opportunities, and emerging strategies

Molecular Oncology, EarlyView.
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley   +1 more source

Beyond a few bases: methods for large DNA insertion and gene targeting in plants. [PDF]

Plant J
Vollen K, Alonso JM, Stepanova AN.
europepmc   +1 more source

Human RNase P: overview of a ribonuclease of interrelated molecular networks and gene-targeting systems. [PDF]

RNA, 2023
Jarrous N, Liu F.
europepmc   +1 more source